Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia.
Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia.
复制标题
经皮腔内肾血管成形术治疗动脉粥样硬化或纤维肌性发育不良引起的肾血管性高血压。
DOI：
--
复制
发表时间：
1983
影响因子：
158.5
通讯作者：
J. Laragh
中科院分区：
文献类型：
--
作者：
T. Sos;T. Pickering;K. Sniderman;S. Saddekni;D. Case;M. Silane;E. Vaughan;J. Laragh
我们尝试对 89 名患有高血压和肾动脉狭窄的患者（包括 51 名动脉粥样硬化患者和 31 名纤维肌性狭窄患者）进行经皮腔内肾血管成形术，然后平均随访 16 个月（范围为 4 至 40 个月）。血管成形术在技术上成功治疗了 87% 的纤维肌性狭窄和 57% 的单侧动脉粥样硬化狭窄，但只有 10% 的双侧动脉粥样硬化狭窄。成功进行血管成形术后，93% 的纤维肌性发育不良患者和 84% 的动脉粥样硬化患者的血压降至正常或改善。对 15 名患者进行平均 21.8 个月的血管造影随访显示，狭窄持续缓解，肾脏大小平均增加 12%。肾血管成形术可有效长期控制因纤维肌性发育不良或单侧非动脉粥样硬化导致肾动脉狭窄的患者的高血压。
We attempted percutaneous transluminal renal angioplasty in 89 patients with hypertension and renal-artery stenosis (including 51 with atheromatous and 31 with fibromuscular stenoses) who were then followed for an average of 16 months (range, 4 to 40). Angioplasty was technically successful in 87 per cent of the fibromuscular stenoses and in 57 per cent of the unilateral atheromatous stenoses but in only 10 per cent of the bilateral atheromatous stenoses. After successful angioplasty, blood pressure was reduced to normal or improved in 93 per cent of the patients with fibromuscular dysplasia and in 84 per cent of the patients with atheromatous disease. Angiographic follow-up at an average of 21.8 months in 15 patients showed persistent relief of the stenoses and a 12 per cent average increase in kidney size. Renal angioplasty is effective for long-term control of hypertension in patients with renal-artery stenosis due to fibromuscular dysplasia or unilateral non-ostial atheroma.
经皮腔内扩张术治疗肾血管性高血压。
影响因子：
39.2
作者：
Grim,CE;Luft,FC;Yune,HY;Klatte,EC;Weinberger,MH
通讯作者：
Weinberger,MH